Chemoinformaics analysis of CIS-11,14-EICOSADIENOIC-ACID
| Molecular Weight | 296.451 | nRot | 14 |
| Heavy Atom Molecular Weight | 264.195 | nRig | 5 |
| Exact Molecular Weight | 296.235 | nRing | 1 |
| Solubility: LogS | -4.605 | nHRing | 1 |
| Solubility: LogP | 5.749 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 53.8034 |
| nHD | 1 | BPOL | 34.7066 |
| QED | 0.276 |
| Synth | 3.125 |
| Natural Product Likeliness | 1.728 |
| NR-PPAR-gamma | 0.985 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.873 |
| MDCK | 0.0000318 |
| BBB | 0.157 |
| PPB | 0.979531 |
| VDSS | 0.586 |
| FU | 0.0156278 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.314 |
| CYP2c19-inh | 0.037 |
| CYP2c19-sub | 0.315 |
| CYP2c9-inh | 0.168 |
| CYP2c9-sub | 0.974 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.111 |
| CYP3a4-inh | 0.029 |
| CYP3a4-sub | 0.026 |
| CL | 3.836 |
| T12 | 0.628 |
| hERG | 0.017 |
| Ames | 0.031 |
| ROA | 0.023 |
| SkinSen | 0.94 |
| Carcinogencity | 0.144 |
| EI | 0.846 |
| Respiratory | 0.667 |
| NR-Aromatase | 0.859 |
| Antiviral | Yes |
| Prediction | 0.588371 |